What is 5-Amino-1MQ? n

5-Amino-1MQ Research: Mechanism, Studies & Data Overview

5-Amino-1MQ is a synthetic small-molecule identified as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme implicated in cellular metabolism and NAD+ homeostasis. Preliminary *in vitro* and *ex vivo* research focuses on understanding its impact within metabolic and NAD-salvage pathways at a foundational level. This compound is strictly for research purposes, with investigations primarily conducted in controlled laboratory environments.

As of the latest review, there are no indexed PubMed publications specifically detailing 5-Amino-1MQ research, nor are there any registered clinical studies on ClinicalTrials.gov involving this specific compound, underscoring its early-stage research status and the imperative for further foundational investigation in appropriate scientific settings.

Understanding Nicotinamide N-Methyltransferase (NNMT) in Research

Nicotinamide N-Methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the N-methylation of nicotinamide to 1-methylnicotinamide (1-MNA). This biochemical reaction is significant in research for two primary reasons: it consumes nicotinamide, a crucial precursor for the coenzyme Nicotinamide Adenine Dinucleotide (NAD+), and it depletes S-adenosyl-L-methionine (SAM), the universal methyl donor. Consequently, NNMT activity plays a pivotal role in modulating both the cellular NAD+ pool and the cellular methylome, influencing a broad spectrum of metabolic and epigenetic processes. Its expression is observed across various mammalian tissues, including the liver, adipose tissue, skeletal muscle, and kidneys, making it a widespread subject of investigation in experimental biology.

The research interest in NNMT stems from its identified role as a key modulator in several physiological and pathophysiological contexts. By converting nicotinamide away from the NAD+ salvage pathway, NNMT directly influences the availability of substrate for NAD+-dependent enzymes such as sirtuins (e.g., SIRT1, SIRT3), which are central to regulating gene expression, DNA repair, and mitochondrial function. Furthermore, the consumption of SAM by NNMT links its activity to the broader one-carbon metabolism and epigenetic modifications, including DNA methylation and histone methylation. Experimental models have explored the implications of altered NNMT expression, ranging from its impact on cellular proliferation and differentiation to its potential involvement in inflammatory responses and stress resilience pathways.

Investigational studies often focus on understanding the precise mechanisms by which NNMT contributes to cellular homeostasis and disease pathogenesis. Researchers utilize various approaches, including genetic manipulation (overexpression or knockdown of NNMT) and pharmacological modulation, to dissect its functional significance. The intricate interplay between NNMT activity, NAD+ metabolism, and methylation pathways presents numerous avenues for hypothesis-driven research. Elucidating the precise regulatory loops and downstream effectors of NNMT remains a critical objective in preclinical research, paving the way for a deeper understanding of cellular metabolism.

The Role of NNMT in Cellular Metabolism: A Research Perspective

From a research perspective, Nicotinamide N-Methyltransferase (NNMT) stands as a critical node in the intricate network of cellular metabolism. Its enzymatic action, which diverts nicotinamide from the NAD+ salvage pathway, directly influences the intracellular NAD+/NADH ratio. This ratio is a fundamental determinant of cellular energy status and redox potential, impacting the activity of numerous metabolic enzymes and signaling molecules. Research has highlighted that NNMT effectively acts as a “metabolic sink” for nicotinamide, thereby indirectly regulating the function of NAD+-dependent sirtuins, which are key deacetylases involved in regulating gene expression related to glucose and lipid metabolism, mitochondrial biogenesis, and stress responses.

Experimental models have provided significant insights into NNMT’s involvement in specific metabolic tissues. In adipose tissue, NNMT expression has been observed to be upregulated in conditions of metabolic dysfunction, such as diet-induced obesity in preclinical models. Investigational studies suggest that NNMT inhibition can alter adipocyte differentiation, reduce lipid accumulation, and improve insulin sensitivity in these research settings. Similarly, in hepatic metabolic processes, NNMT has been implicated in regulating lipid homeostasis and glucose production. Researchers are exploring how NNMT activity may influence processes such as fatty acid oxidation, gluconeogenesis, and cholesterol synthesis within the liver, using both in vitro and in vivo experimental systems.

NNMT and NAD+ Salvage Pathways: Exploring the Connection

The relationship between NNMT and NAD+ salvage pathways is a central theme in metabolic research. By converting nicotinamide into 1-methylnicotinamide, NNMT reduces the availability of nicotinamide for conversion to Nicotinamide Mononucleotide (NMN) by Nicotinamide Phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the NAD+ salvage pathway. This reduction in precursor availability can lead to lower intracellular NAD+ levels. Research hypotheses suggest that inhibiting NNMT could enhance the flux through the NAD+ salvage pathway, thereby boosting NAD+ levels and potentially activating downstream NAD+-dependent processes. This connection makes NNMT a compelling target for research into strategies aimed at modulating cellular NAD+ pools, which are often observed to decline with aging and in various metabolic disturbances in experimental models. Further exploration into this mechanism is available on our dedicated page: 5-Amino-1MQ Mechanism of Action.

Moreover, the depletion of SAM by NNMT links its metabolic role to the epigenome. SAM is crucial for countless cellular methylation reactions, and its consumption by NNMT can lead to global hypomethylation or localized changes in methylation patterns, influencing gene expression and protein function. Understanding the delicate balance between NNMT activity, NAD+ biosynthesis, and cellular methylation status is a complex area of ongoing research, with implications for understanding cellular adaptive responses to metabolic stress in various experimental models.

Amino-1MQ: Chemical Structure and Properties for Laboratory Study

5-Amino-1MQ is a small-molecule NNMT inhibitor, specifically developed and investigated for its capacity to interfere with the enzymatic activity of Nicotinamide N-Methyltransferase. As a research compound, its precise chemical structure and well-characterized properties are paramount for reproducible and reliable laboratory studies. Chemically, 5-Amino-1MQ is identified as 1-methyl-5-amino-1H-quinazolin-4-one, a quinazoline derivative. Its molecular formula is C9H9N3O, and it possesses a molecular weight that is characteristic of a small organic molecule, enabling its utility in various biochemical and cellular assays. The specific positioning of the amino group at the 5-position and the methyl group at the 1-position of the quinazolinone core is critical for its interaction with the NNMT enzyme.

For laboratory applications, understanding the physical and chemical characteristics of 5-Amino-1MQ is essential for proper handling, storage, and experimental design. Royal Peptide Labs ensures the provision of high-purity research compounds, and researchers should always consult the Certificate of Analysis (COA) for specific batch details regarding purity, identity, and concentration. Typically, 5-Amino-1MQ is supplied as a white to off-white crystalline solid. Its solubility profile is crucial for preparing stock solutions; it is generally soluble in organic solvents such as dimethyl sulfoxide (DMSO) and can be solubilized in aqueous solutions, often requiring slight pH adjustment or cosolvents depending on the desired concentration for experimental work.

Key Properties for Research Protocol Development

Researchers designing protocols involving 5-Amino-1MQ should consider the following key properties:

Property	Typical Characteristics for Research Grade Material
Purity	>98% (determined by HPLC) essential for accurate and consistent experimental results.
Appearance	White to off-white crystalline powder.
Solubility	Soluble in DMSO; sparingly soluble in water, may require gentle warming or sonication for dissolution in aqueous buffers.
Stability	Stable under recommended storage conditions (e.g., cool, dry, dark, desiccated). Solutions should be prepared fresh or stored properly to maintain integrity.
Molecular Weight	175.19 g/mol (C9H9N3O), critical for precise molar calculations in experimental setups.

Proper storage and handling are critical to maintaining the integrity and efficacy of 5-Amino-1MQ. The compound should be stored in a tightly sealed container, protected from light and moisture, typically at -20°C for long-term preservation. When preparing solutions, researchers should use appropriate laboratory safety practices and sterile techniques to prevent contamination and degradation. The accurate characterization of 5-Amino-1MQ and its potential metabolites is also a crucial aspect of rigorous research, ensuring that observed biological effects are directly attributable to the intended compound.

Proposed Mechanism of Action: 5-Amino-1MQ as an NNMT Inhibitor

Nicotinamide N-methyltransferase (NNMT) is an enzyme primarily localized in the cytoplasm, recognized for its critical role in cellular metabolism through the methylation of nicotinamide (NAM). This enzymatic reaction consumes S-adenosylmethionine (SAM) as a methyl donor and converts nicotinamide into 1-methylnicotinamide (1-MNA). In the context of metabolic research, NNMT’s activity is a focal point due to its capacity to regulate intracellular nicotinamide levels, thereby indirectly influencing the availability of substrate for NAD+ salvage pathways. Understanding the precise biochemical role of NNMT is paramount for investigating its broader implications in various biological systems.

5-Amino-1MQ is investigated as a small-molecule inhibitor designed to specifically target and modulate the activity of the NNMT enzyme. The proposed mechanism of action centers on its ability to bind to the NNMT active site, thereby preventing the enzyme from methylating nicotinamide. While detailed kinetic and structural studies characterizing 5-Amino-1MQ’s binding to NNMT are subjects of ongoing or future research, the foundational hypothesis posits that this binding leads to a competitive or non-competitive inhibition, effectively reducing the conversion of nicotinamide to 1-MNA. This inhibition is anticipated to lead to a significant alteration in the cellular metabolic landscape, particularly concerning the nicotinamide adenine dinucleotide (NAD+) pool.

The primary consequence of NNMT inhibition by 5-Amino-1MQ, as explored in research, is the elevation of intracellular nicotinamide concentrations. By limiting the methylation of nicotinamide, more of this crucial precursor becomes available within the cell. This increase in substrate availability is hypothesized to have a direct impact on the subsequent metabolic pathways that utilize nicotinamide, most notably the NAD+ salvage pathway. Therefore, 5-Amino-1MQ serves as a valuable tool for researchers aiming to experimentally manipulate nicotinamide and NAD+ levels to observe downstream metabolic effects. Ensuring the purity and identity of such research compounds, validated through Certificates of Analysis, is critical for reliable experimental outcomes.

NNMT Inhibition and NAD+ Salvage Pathways: Exploring the Connection

The regulation of nicotinamide adenine dinucleotide (NAD+) levels is a central theme in metabolic research, given its essential role as a coenzyme in numerous catabolic and anabolic reactions, as well as a substrate for NAD+-dependent enzymes like sirtuins (SIRT1-7) and poly(ADP-ribose) polymerases (PARPs). Cells maintain NAD+ homeostasis through a complex interplay of synthesis, consumption, and salvage pathways. Among these, the NAD+ salvage pathway, primarily mediated by nicotinamide phosphoribosyltransferase (NAMPT), is critical for recycling nicotinamide back into NAD+. NAMPT catalyzes the rate-limiting step, converting nicotinamide to nicotinamide mononucleotide (NMN), which is then further converted to NAD+.

As previously discussed, the proposed mechanism of 5-Amino-1MQ involves the inhibition of NNMT, which diverts nicotinamide from its methylation pathway. This action is hypothesized to lead to an increased intracellular pool of unmethylated nicotinamide. In turn, this elevated nicotinamide concentration is expected to serve as an enhanced substrate for NAMPT, thereby potentially boosting the activity of the NAD+ salvage pathway. Research studies are designed to investigate whether this increased substrate availability effectively accelerates the conversion of nicotinamide to NMN and subsequently to NAD+, thus raising intracellular NAD+ levels.

The exploration of this connection between NNMT inhibition and NAD+ salvage pathways offers a promising avenue for understanding metabolic regulation. Elevated NAD+ levels, resulting from enhanced salvage, are hypothesized to influence the activity of NAD+-dependent enzymes. For instance, increased NAD+ availability could potentially upregulate the deacetylase activity of sirtuins, particularly SIRT1, which plays a pivotal role in cellular energy metabolism, stress resistance, and gene expression. Researchers can utilize 5-Amino-1MQ to experimentally probe the functional consequences of modulated NAD+ pools on these enzyme activities and the broader metabolic phenotype in various experimental models, from cell cultures to animal studies. This research aims to elucidate the intricate metabolic cascade initiated by NNMT inhibition.

Investigating 5-Amino-1MQ’s Impact on Adipose Tissue Metabolism in Experimental Models

Adipose tissue, commonly known as fat, is a highly dynamic and metabolically active organ beyond its primary role in energy storage. It plays crucial roles in systemic energy homeostasis, endocrine signaling, and thermogenesis, existing in distinct forms such as white adipose tissue (WAT) and brown adipose tissue (BAT). NNMT is known to be expressed in adipocytes, and its levels and activity can vary depending on tissue type and metabolic state. Therefore, targeting NNMT with compounds like 5-Amino-1MQ represents a compelling area of investigation for researchers exploring novel strategies to modulate adipose tissue function and metabolism in experimental models.

Research hypotheses surrounding 5-Amino-1MQ’s effects on adipose tissue metabolism often center on the premise that NNMT inhibition will lead to increased NAD+ levels within adipocytes, subsequently influencing key metabolic pathways. For instance, enhanced NAD+ availability could modulate SIRT1 activity, which is known to regulate lipid metabolism, mitochondrial biogenesis, and inflammation in adipose tissue. Experimental models are designed to examine how 5-Amino-1MQ influences processes such as lipolysis (fat breakdown), lipogenesis (fat synthesis), fatty acid oxidation, mitochondrial respiration, and adipokine secretion (e.g., leptin, adiponectin). These investigations aim to unravel the intricate cellular and molecular adaptations in response to NNMT inhibition.

To effectively study 5-Amino-1MQ’s impact, a range of experimental models and analytical approaches are employed. In vitro studies often utilize pre-adipocyte cell lines (e.g., 3T3-L1) differentiated into mature adipocytes, allowing for controlled examination of cellular processes. Ex vivo approaches might involve incubating isolated adipose tissue explants with the compound. Furthermore, various in vivo rodent models, including those exhibiting diet-induced metabolic dysfunction, are used to assess systemic effects and tissue-specific responses. The rigorous design and execution of these studies, supported by comprehensive quality testing of research compounds, are essential for generating reliable and reproducible data.

Key Research Endpoints in Adipose Tissue Studies

Gene Expression Analysis: Quantifying mRNA levels of key enzymes and transcription factors involved in lipid metabolism (e.g., FAS, HSL, ATGL), mitochondrial function (e.g., PGC-1α, UCP1), and inflammatory pathways (e.g., TNF-α, IL-6).
Protein Expression and Activity: Measuring levels of target proteins via Western blot or immunohistochemistry, and assessing enzymatic activities (e.g., lipases, respiratory chain complexes).
Lipidomics and Metabolomics: Profiling changes in lipid species, fatty acids, and other metabolites within adipocytes or adipose tissue to understand metabolic flux.
Mitochondrial Function Assays: Evaluating oxygen consumption rates, ATP production, and mitochondrial biogenesis markers to determine effects on energy expenditure.
Adipokine Secretion: Measuring the release of hormones and signaling molecules from adipocytes into the culture media or systemic circulation in animal models.
Morphological Analysis: Assessing adipocyte size, number, and overall tissue architecture using histological techniques.

These multifaceted approaches contribute to a comprehensive understanding of how NNMT inhibition, mediated by 5-Amino-1MQ, influences the complex metabolic processes within adipose tissue.

Examining Hepatic Metabolic Processes in Response to 5-Amino-1MQ in Research Settings

The liver stands as a pivotal organ in the regulation of systemic metabolism, orchestrating processes such as glucose homeostasis, lipid synthesis, and detoxification. Research into compounds like 5-Amino-1MQ, an NNMT inhibitor, often explores its potential impact on hepatic metabolic processes due to the liver’s significant NNMT expression and its central role in NAD+ metabolism. Nicotinamide N-methyltransferase (NNMT) is an enzyme that catalyzes the methylation of nicotinamide, consuming S-adenosylmethionine (SAM) and producing 1-methylnicotinamide (1-MNA). By depleting intracellular nicotinamide, NNMT activity can influence the cellular NAD+ pool, a coenzyme critical for numerous metabolic pathways, including those governed by sirtuins and other NAD+-dependent enzymes.

In various experimental models, researchers investigate how NNMT inhibition by 5-Amino-1MQ might modulate key hepatic functions. Studies could focus on evaluating changes in hepatic glucose output, a crucial function for maintaining blood glucose levels. Researchers might explore if NNMT inhibition influences gluconeogenesis or glycogenolysis pathways. Similarly, the liver’s role in lipid metabolism, encompassing fatty acid synthesis, oxidation, and triglyceride formation, presents another significant area of inquiry. Alterations in these pathways could be examined through assessment of gene expression profiles, enzyme activities, and intracellular metabolite concentrations within isolated hepatocytes or liver tissue samples following exposure to 5-Amino-1MQ in controlled research environments.

Furthermore, the interplay between NNMT inhibition and the availability of SAM, a universal methyl donor, is of interest in hepatic research. NNMT consumes SAM, so its inhibition could theoretically conserve SAM levels, potentially influencing other methylation reactions vital for liver function and epigenetics. Researchers might also assess the impact on mitochondrial respiration and energy production within liver cells, as NAD+ levels are intimately linked to the electron transport chain. The overall objective of these early-stage investigations is to elucidate the mechanistic connections between NNMT activity, NAD+ dynamics, SAM availability, and specific hepatic metabolic pathways, thereby building a foundational understanding of 5-Amino-1MQ’s research profile.

The Interplay of 5-Amino-1MQ, SIRT1, and Metabolic Regulation: A Research Hypothesis

SIRT1, a highly conserved NAD+-dependent deacetylase, plays a critical role in cellular energy homeostasis and metabolic regulation across various tissues, including the liver, adipose tissue, and muscle. Its activity is directly dependent on the availability of NAD+, functioning as a sensor of the cell’s metabolic state. A primary research hypothesis surrounding 5-Amino-1MQ centers on the premise that its inhibition of NNMT could lead to an increase in intracellular NAD+ levels. This elevation in NAD+ could, in turn, enhance SIRT1 activity, thereby indirectly influencing a cascade of downstream metabolic processes.

The proposed mechanism suggests that by reducing the methylation of nicotinamide into 1-methylnicotinamide, 5-Amino-1MQ preserves nicotinamide within the cell. Nicotinamide can then be recycled back into NAD+ via the NAD+ salvage pathway. An increase in NAD+ availability provides more substrate for SIRT1, potentially leading to greater deacetylation of its target proteins. These targets include enzymes involved in glucose and lipid metabolism, transcription factors regulating mitochondrial biogenesis, and proteins influencing cellular stress responses. For instance, enhanced SIRT1 activity is associated with improved mitochondrial function, altered gene expression profiles related to fatty acid oxidation, and modulation of inflammatory pathways in various experimental models.

Therefore, researchers are exploring whether 5-Amino-1MQ’s potential to boost NAD+ and subsequent SIRT1 activity could contribute to observed metabolic effects in research models. This line of inquiry involves studying changes in the acetylation status of known SIRT1 substrates, measuring NAD+/NADH ratios, and analyzing the expression of SIRT1-regulated genes and proteins in cell culture or animal models exposed to 5-Amino-1MQ. Such investigations aim to uncover the precise molecular links connecting NNMT inhibition, NAD+ levels, SIRT1 activity, and overarching metabolic regulation. For a more detailed understanding of this compound’s operational mechanics, researchers may consult resources on the Proposed Mechanism of Action: 5-Amino-1MQ as an NNMT Inhibitor.

Early-Stage Research: In Vitro and Ex Vivo Models for 5-Amino-1MQ Studies

Early-stage research on novel compounds like 5-Amino-1MQ typically commences with controlled studies in simplified laboratory models to establish foundational understanding of their biological effects and mechanisms. These initial investigations primarily utilize in vitro (cell culture) and ex vivo (tissue explant) systems, offering a highly controlled environment for studying cellular responses without the complexities of a whole organism. It is important to note that as of current reporting, there are 0 PubMed publications indexed and 0 ClinicalTrials.gov registered studies directly involving 5-Amino-1MQ, underscoring the early, exploratory nature of its research landscape.

In Vitro Models

In vitro studies leverage various cell lines or primary cell cultures to investigate the direct effects of 5-Amino-1MQ on specific cell types. Common models include:

Hepatocytes: To study hepatic metabolic pathways, including glucose and lipid metabolism, as well as NAD+ turnover.
Adipocytes: Both pre-adipocyte cell lines (e.g., 3T3-L1) and primary human/animal adipocytes are used to examine effects on lipogenesis, lipolysis, and energy expenditure.
Skeletal Muscle Cells: To investigate impacts on glucose uptake, mitochondrial function, and fatty acid oxidation.
Pancreatic Beta Cells: For exploring potential influences on insulin secretion and glucose sensing.

In these models, researchers can measure NNMT activity inhibition, NAD+/NADH ratios, gene and protein expression related to metabolic pathways (e.g., using qPCR, Western blot), cellular respiration, ATP levels, and the production of specific metabolites. These controlled environments allow for precise dose-response studies and mechanistic investigations.

Ex Vivo Models

Ex vivo models provide a bridge between in vitro cellular studies and more complex in vivo animal models. They involve isolating organs or tissue fragments from animals and maintaining them in a viable state for short-term experimentation. This approach retains the tissue architecture and cell-cell interactions, offering a more physiologically relevant context than isolated cells.

Ex Vivo Model Type	Primary Research Application	Example Metrics for 5-Amino-1MQ
Liver Slices	Hepatic glucose & lipid metabolism, NAD+ levels	Glucose production, triglyceride synthesis, NAD+ flux
Adipose Tissue Explants	Adipokine secretion, lipolysis, glucose uptake	Glycerol release, cytokine secretion, glucose transport
Skeletal Muscle Bundles	Insulin sensitivity, mitochondrial respiration	Glucose uptake, oxygen consumption rates (OCR)

Both in vitro and ex vivo models are instrumental for generating initial hypotheses and confirming basic mechanisms of action for 5-Amino-1MQ. However, their limitations, such as lack of systemic physiological regulation and short study durations, necessitate progression to more complex in vivo models for comprehensive understanding. Researchers embarking on such studies should prioritize the purity and consistency of their research materials, ensuring robust and reproducible results, which can be verified through rigorous quality testing protocols.

Considerations for Designing 5-Amino-1MQ Research Protocols

The design of robust and reliable research protocols for investigating 5-Amino-1MQ is paramount to generating scientifically sound data. As an NNMT inhibitor under early investigation, studies must be meticulously planned to ensure that results accurately reflect the compound’s actions and properties within controlled experimental conditions. Researchers must consider several critical elements, from the quality of the starting material to the selection of appropriate experimental models and the precise definition of outcome measures.

Purity and Characterization of Research Material

A foundational step in any research involving 5-Amino-1MQ is the rigorous assessment of the compound’s purity and identity. Impurities can confound experimental results, leading to misinterpretations of mechanistic actions or dose-response relationships. Researchers should procure 5-Amino-1MQ from reputable suppliers and verify its specifications through a Certificate of Analysis (COA). Critical characterization data, such as high-performance liquid chromatography (HPLC) for purity, mass spectrometry (MS) for molecular weight, and nuclear magnetic resonance (NMR) for structural confirmation, are essential. This due diligence helps ensure experimental reproducibility and the validity of findings. For details on our quality assurance processes, please refer to our quality testing information.

Experimental Model Selection and Dosing Strategies

The choice of experimental model profoundly impacts the relevance and translatability of research findings. For 5-Amino-1MQ, given its proposed role in metabolic and NAD-salvage research, common models include various cell lines (e.g., adipocytes, hepatocytes), primary cell cultures, organoids, and in vivo animal models (e.g., rodent models of metabolic dysfunction). Dose-response studies are critical to establish effective concentrations or dosages that elicit a desired biological effect without inducing non-specific toxicity. Researchers typically initiate with a broad range of concentrations/doses, gradually refining the range based on preliminary observations. Consideration must be given to the compound’s solubility, stability in culture media or physiological solutions, and appropriate administration routes for in vivo studies (e.g., oral gavage, intraperitoneal injection, subcutaneous).

Defining Research Endpoints and Controls

Clear definition of research endpoints is crucial for quantitative assessment of 5-Amino-1MQ’s effects. Given its mechanism as an NNMT inhibitor, relevant endpoints include measurement of NNMT activity, levels of nicotinamide (NAM), N-methylnicotinamide (MNA), and NAD+ pathway metabolites. Downstream metabolic effects could involve assessment of glucose uptake, lipid synthesis, oxygen consumption, mitochondrial function, gene expression (e.g., related to fatty acid oxidation, glycolysis), and protein levels (e.g., SIRT1, AMPK). Robust experimental design necessitates appropriate control groups, including vehicle-treated controls (using the solvent or carrier for 5-Amino-1MQ), untreated controls, and potentially positive controls (known NNMT inhibitors or metabolic modulators) to benchmark expected responses. Ethical considerations, including institutional animal care and use committee (IACUC) or institutional review board (IRB) approvals for animal or human-derived tissue studies, must be strictly observed.

Analytical Methods for Characterizing 5-Amino-1MQ and its Metabolites in Research

Effective investigation into 5-Amino-1MQ’s properties and biological impact requires sophisticated analytical methodologies capable of accurately identifying, quantifying, and tracking the compound and its potential metabolites within various research matrices. These methods are essential for confirming the integrity of the research material, understanding its pharmacokinetic profile in experimental models, and elucidating its metabolic fate.

Primary Compound Characterization

Prior to initiating biological studies, comprehensive characterization of 5-Amino-1MQ itself is fundamental.

High-Performance Liquid Chromatography (HPLC): Often coupled with UV detection (HPLC-UV) or mass spectrometry (HPLC-MS), this technique is used to determine the purity of the synthesized compound and to quantify it. Preparative HPLC may also be employed for purification.
Mass Spectrometry (MS): Provides accurate molecular weight information and can confirm the molecular formula. High-resolution mass spectrometry (HRMS) offers even greater precision, aiding in the identification of subtle impurities or degradation products.
Nuclear Magnetic Resonance (NMR) Spectroscopy: Both ¹H NMR and ¹³C NMR are critical for confirming the chemical structure of 5-Amino-1MQ, providing detailed information about atomic connectivity and molecular conformation.
Infrared (IR) Spectroscopy: Useful for identifying key functional groups within the molecule, corroborating structural assignments from NMR.

These methods collectively establish a robust chemical identity for the research material, which is a prerequisite for reliable experimental outcomes.

Quantification in Biological Matrices

Quantifying 5-Amino-1MQ and its metabolites in biological samples (e.g., cell lysates, tissue homogenates, plasma, urine) is essential for pharmacokinetic (PK) and pharmacodynamic (PD) studies.

Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS)

LC-MS/MS is the gold standard for quantifying small molecules in complex biological matrices due to its high sensitivity, selectivity, and throughput. Samples typically undergo extraction (e.g., protein precipitation, solid-phase extraction) to remove interfering matrix components. The extracted analytes are then separated by liquid chromatography and detected using tandem mass spectrometry. This technique can accurately measure parent compound levels over time, providing critical data on absorption, distribution, metabolism, and excretion in experimental models.

Metabolite Identification and Profiling

Understanding how 5-Amino-1MQ is metabolized in biological systems is crucial for interpreting its effects and identifying potential active or inactive metabolites.

Strategies for Metabolite Identification

Metabolite identification often begins with in vitro studies using liver microsomes or hepatocytes, which can predict major metabolic pathways. These findings are then corroborated and expanded through in vivo studies in animal models, analyzing samples such as plasma, urine, and tissue extracts.

Techniques for Metabolite Analysis

Advanced MS techniques are predominantly used for metabolite identification. LC-HRMS, particularly with data-dependent or data-independent acquisition strategies, can detect and characterize unknown metabolites by comparing mass spectral patterns between treated and control samples. By observing mass shifts characteristic of common metabolic transformations (e.g., hydroxylation, glucuronidation, methylation), potential metabolites can be tentatively identified and then confirmed using synthetic standards if available, or by further fragmentation analysis. Given 5-Amino-1MQ’s structure, researchers might be particularly interested in identifying metabolites that retain or alter its NNMT inhibitory properties.

Current Landscape of 5-Amino-1MQ Research: Peer-Reviewed Literature Status

The scientific understanding and validation of any novel compound progress through a rigorous, multi-stage process, typically culminating in peer-reviewed publications. For 5-Amino-1MQ, a compound classified as an NNMT inhibitor studied in metabolic and NAD-salvage research, its journey through this landscape is currently in its nascent stages.

Absence of Indexed Peer-Reviewed Publications and Clinical Trials

As of the latest assessment, the research profile of 5-Amino-1MQ indicates a distinct and early phase of investigation. Specifically:

Research Database	Status for 5-Amino-1MQ
PubMed Publications Indexed	0
ClinicalTrials.gov Registered Studies	0

The absence of indexed publications on PubMed signifies that there are currently no formal, publicly available peer-reviewed scientific articles detailing research specific to 5-Amino-1MQ. Similarly, no registered studies on ClinicalTrials.gov indicate that no human clinical trials involving 5-Amino-1MQ are currently underway or have been reported to this public registry. This status underscores that 5-Amino-1MQ is strictly in the realm of early-stage, foundational research, primarily confined to laboratory and experimental model investigations.

Implications for the Research Community

This current landscape means that researchers interested in 5-Amino-1MQ are at the forefront of establishing its scientific credibility and understanding. Studies at this stage are crucial for:

Mechanistic Elucidation: Confirming its proposed mechanism of action as an NNMT inhibitor and exploring any off-target effects.
In Vitro Validation: Establishing dose-response curves, specificity, and efficacy in various cell-based models.
In Vivo Characterization: Investigating its effects in animal models relevant to metabolic research, including pharmacokinetic and pharmacodynamic profiling.
Safety and Toxicity Profiling: Identifying potential toxicities or adverse effects in experimental systems.

The lack of existing literature places a greater responsibility on individual researchers to conduct thorough, well-controlled studies and to openly share their findings, potentially through pre-print servers, conference presentations, or eventually, peer-reviewed journals. Royal Peptide Labs recognizes this early stage and provides high-purity 5-Amino-1MQ for research to facilitate these critical initial investigations.

Future Directions and Contributing to Knowledge

The future research landscape for 5-Amino-1MQ is dependent upon the outcomes of ongoing and future laboratory investigations. The first peer-reviewed publications will mark a significant milestone, providing initial validation and forming the basis for subsequent, more extensive research. As research progresses, independent replication of results will be vital for building scientific consensus around 5-Amino-1MQ’s potential utility as a research tool for studying NNMT inhibition and its implications for metabolic and NAD+ salvage pathways. The scientific community eagerly anticipates the rigorous studies that will shape our understanding of this compound.

Ethical Considerations and Responsible Conduct of 5-Amino-1MQ Research

The investigation of novel research compounds like 5-Amino-1MQ, particularly those in early stages of inquiry with no indexed peer-reviewed publications or registered clinical trials, necessitates a robust framework of ethical considerations and responsible conduct. Researchers utilizing 5-Amino-1MQ must operate strictly within a “research-use-only” paradigm, recognizing that the compound’s potential biological activities are subject to ongoing discovery and have not been characterized for any therapeutic or diagnostic application. This foundational principle dictates that all experimental work, whether in vitro, ex vivo, or in vivo (in animal models), must be designed and executed with the highest degree of scientific integrity, transparency, and adherence to relevant regulatory and institutional guidelines.

Key ethical mandates include ensuring the humane treatment of research animals, where applicable, in strict compliance with Institutional Animal Care and Use Committee (IACUC) protocols. For studies involving human-derived cells or tissues, Institutional Review Board (IRB) approval and strict adherence to informed consent processes are paramount. Furthermore, meticulous record-keeping is essential, covering experimental design, methodologies, raw data, and data analysis. This commitment to transparency supports reproducibility, a cornerstone of sound scientific practice, and allows for critical evaluation by the broader scientific community. Researchers should explicitly state the “research-use-only” nature of 5-Amino-1MQ in all communications, presentations, and publications, preventing any misinterpretation of its current status.

Ensuring Compound Integrity and Purity for Research

A critical aspect of responsible research is the assurance of the compound’s identity, purity, and stability. Variability in research outcomes can often be traced back to inconsistencies in the quality of the research material itself. Therefore, researchers must source 5-Amino-1MQ from reputable suppliers that provide comprehensive analytical documentation, such as Certificates of Analysis (CoA). These documents should detail the compound’s chemical identity, purity levels (e.g., via HPLC), and absence of significant contaminants. Implementing internal quality checks, where feasible, further reinforces the reliability of experimental inputs. Understanding the rigorous quality testing procedures employed by suppliers helps establish a foundation of trust in the integrity of the research compound, ultimately contributing to the validity and reproducibility of scientific findings.

Mitigating Misinformation and Misuse

Given the rapidly evolving landscape of research compounds, researchers bear a responsibility to prevent the misuse or misinterpretation of their findings. This includes refraining from speculative claims about 5-Amino-1MQ’s potential for human health or disease treatment, especially in early-stage research. The communication of research results should be precise, factual, and contextualized within the experimental limitations. Emphasizing the distinction between foundational biological research and clinical application is crucial to managing public expectations and preventing individuals from attempting self-experimentation or drawing premature conclusions. Responsible conduct extends to the safe handling, storage, and disposal of 5-Amino-1MQ, adhering to laboratory safety protocols and environmental regulations to protect personnel and the environment from potential hazards associated with novel chemical entities.

Future Directions and Unanswered Questions in 5-Amino-1MQ Research

The current landscape for 5-Amino-1MQ research is characterized by its foundational nature, with 0 PubMed publications and 0 ClinicalTrials.gov registered studies. This status highlights a vast frontier for exploration, positioning 5-Amino-1MQ as a tool for initial investigation into Nicotinamide N-Methyltransferase (NNMT) inhibition and its broad implications for metabolic and NAD-salvage pathways. The immediate future of 5-Amino-1MQ research will largely focus on elucidating its precise pharmacological profile, dissecting its mechanistic interplay at a finer resolution, and exploring its effects across a wider array of biological systems and models. These early-stage studies are vital for establishing a comprehensive understanding of the compound’s utility in research.

A primary unanswered question revolves around the full spectrum of downstream effects initiated by NNMT inhibition via 5-Amino-1MQ. While NNMT inhibition is known to influence cellular NAD+ levels and subsequent metabolic processes, the specific and comprehensive metabolic rewiring across different cell types and tissues remains to be fully mapped. Researchers may investigate:

Specificity and Selectivity: Confirming the compound’s high specificity for NNMT and identifying any potential off-target effects at various concentrations in diverse biological systems.
Dose-Response Kinetics: Precisely determining optimal concentrations for in vitro studies and effective dosages in various preclinical models to achieve desired NNMT inhibition without overt toxicity.
Metabolomic Profiling: Conducting comprehensive metabolomic and lipidomic analyses in response to 5-Amino-1MQ treatment in relevant cellular and animal models to identify subtle and broad metabolic shifts.
Long-Term Effects: Exploring the effects of chronic NNMT inhibition in suitable experimental models to understand potential adaptive responses or cumulative impacts on cellular function and physiology.

These investigations are crucial for building a robust evidence base for 5-Amino-1MQ’s role as a research tool.

Exploring Broader Metabolic Intersections

Beyond the direct impact on NAD+ metabolism, future research will undoubtedly delve into the broader implications of 5-Amino-1MQ’s NNMT inhibition on interconnected metabolic pathways. This includes detailed studies on its influence on mitochondrial function, oxidative stress, inflammation, and cellular energetic states. Given the proposed connection to SIRT1 in the page outline, further research is warranted to validate and quantify this interplay, exploring how NNMT inhibition might indirectly modulate sirtuin activity and associated longevity pathways. Investigations into how 5-Amino-1MQ impacts different metabolic states (e.g., fed vs. fasted, high-fat diet models) in preclinical settings could reveal nuanced effects on substrate utilization and energy expenditure.

Pharmacokinetic and pharmacodynamic (PK/PD) characterization of 5-Amino-1MQ in relevant experimental models represents another critical area of future inquiry. Understanding its absorption, distribution, metabolism, and excretion in animal systems is essential for designing effective in vivo studies and interpreting their results accurately. Researchers will also need to address potential limitations, such as challenges in compound delivery, stability in biological matrices, and the possibility of differential responses across genetically distinct research models. As a nascent research compound, a deeper understanding of 5-Amino-1MQ’s precise mechanism of action will continue to be a central focus, guiding future experimental designs and interpretations.

Summary of 5-Amino-1MQ’s Research Profile

5-Amino-1MQ stands as a novel small-molecule Nicotinamide N-Methyltransferase (NNMT) inhibitor, positioned exclusively as a research-use-only compound within the scientific community. Its mechanism of action revolves around the inhibition of NNMT, an enzyme recognized for its role in cellular metabolism and the NAD-salvage pathway. The interest in 5-Amino-1MQ stems from the broader research into NNMT’s influence on NAD+ homeostasis, energy regulation, and its potential implications across various metabolic tissues, including adipose tissue and the liver, as suggested by the overarching research page outline.

Currently, the research profile of 5-Amino-1MQ reflects its very early stage of investigation. As of the latest assessment, there are 0 PubMed publications indexed for 5-Amino-1MQ, and 0 registered studies on ClinicalTrials.gov. This critical data point underscores that all current and prospective applications of 5-Amino-1MQ are confined to foundational scientific inquiry, primarily within in vitro and preclinical animal models. Researchers are exploring its fundamental effects on cellular and systemic metabolism, aiming to unravel the intricate roles of NNMT inhibition in biological processes.

Current Research Focus and Scope

The overarching research page outline delineates a comprehensive scope for investigating 5-Amino-1MQ, focusing on several key areas:

Research Area	Description
NNMT Inhibition	Understanding 5-Amino-1MQ’s specific role as an NNMT inhibitor and its impact on NAD+ salvage pathways.
Adipose Tissue Metabolism	Investigating its influence on fat tissue metabolism in experimental models.
Hepatic Metabolic Processes	Examining its effects on liver metabolic functions within research settings.
SIRT1 and Metabolic Regulation	Hypothesizing and exploring the interplay between 5-Amino-1MQ, SIRT1, and broader metabolic control mechanisms.
Early-Stage Models	Utilizing in vitro and ex vivo models for initial characterization and study design.

These areas collectively aim to establish a scientific understanding of how modulating NNMT activity with 5-Amino-1MQ might influence crucial physiological pathways. The absence of published literature means that researchers are largely working on the forefront of discovery, contributing to the initial body of knowledge regarding this specific compound. The insights gained from these foundational studies will be crucial for guiding subsequent research endeavors and hypotheses formation.

In conclusion, 5-Amino-1MQ serves as a valuable tool for scientific exploration into NNMT biology and its metabolic ramifications. Its status as an unresearched compound in the peer-reviewed and clinical trial domains necessitates rigorous adherence to research-use-only principles. Royal Peptide Labs emphasizes the importance of responsible research practices, accurate data interpretation, and strict compliance with ethical guidelines for all investigations involving 5-Amino-1MQ, ensuring that its utility remains within the realm of discovery and foundational scientific inquiry.

Frequently Asked Questions

What is 5-Amino-1MQ?

5-Amino-1MQ is a small-molecule NNMT inhibitor currently under investigation in metabolic and NAD-salvage research. Its utility is strictly for laboratory research applications.

What is the proposed mechanism of action for 5-Amino-1MQ?

Q: What is the proposed mechanism of action for 5-Amino-1MQ?

A: 5-Amino-1MQ functions as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in various metabolic pathways. Research explores its potential impact on NAD+ levels and energy metabolism in cellular and animal models.

Are there any peer-reviewed scientific publications specifically on 5-Amino-1MQ?

Q: Are there any peer-reviewed scientific publications specifically on 5-Amino-1MQ?

A: As of the current data, scientific literature indexed on PubMed shows 0 direct publications specifically on 5-Amino-1MQ. Researchers interested in this compound’s potential should consider broader literature concerning NNMT inhibitors and their role in metabolic research to contextualize its study.

Has 5-Amino-1MQ been studied in human clinical trials?

Q: Has 5-Amino-1MQ been studied in human clinical trials?

A: No. According to the current data on ClinicalTrials.gov, there are 0 registered clinical studies specifically for 5-Amino-1MQ. This compound is strictly intended for in vitro or animal research applications only.

What are the typical research applications for NNMT inhibitors like 5-Amino-1MQ?

Q: What are the typical research applications for NNMT inhibitors like 5-Amino-1MQ?

A: Researchers often investigate NNMT inhibitors in studies related to metabolic regulation, energy homeostasis, NAD+ biosynthesis, and cellular processes. These studies are conducted using various in vitro cell cultures and in vivo non-human animal models to understand fundamental biological mechanisms.

What precautions should be taken when handling 5-Amino-1MQ in a laboratory setting?

Q: What precautions should be taken when handling 5-Amino-1MQ in a laboratory setting?

A: As with any research chemical, standard laboratory safety protocols must be followed. This includes wearing appropriate personal protective equipment (PPE), ensuring adequate ventilation, and consulting the Safety Data Sheet (SDS) for specific handling, storage, and disposal information. It is strictly for laboratory research and not for human consumption.

How should 5-Amino-1MQ be stored for optimal research integrity?

Q: How should 5-Amino-1MQ be stored for optimal research integrity?

A: For optimal stability and to maintain its research integrity, 5-Amino-1MQ should be stored according to the recommendations provided on the product label and SDS. This typically involves storage in a cool, dry, dark place, away from direct light and moisture, and ensuring the container is tightly sealed.

Can 5-Amino-1MQ be used for purposes other than laboratory research?

Q: Can 5-Amino-1MQ be used for purposes other than laboratory research?

A: No. 5-Amino-1MQ is exclusively for research use only. It is not intended for human consumption, therapeutic use, diagnostic purposes, or any application outside of controlled laboratory experimentation. Any other use is strictly prohibited.

Scientific References

All information from Royal Peptide Labs is provided for in-vitro laboratory and research use only — not for human, veterinary, diagnostic, or therapeutic use.